Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-362-1 | CAS number: 58-08-2
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In a dermal sensitization study (RCC, 2005) with anhydrous caffeine (purity >= 99.5% in ethanol:water, 70:30 % (w/v), young adult CBA mice (4 females/group) were tested using the method of the Local Lymph Node Assay. Three groups of mice were applied caffeine at concentrations of 0.5, 2, or 5% (w/v) to the dorsal surface of each ear lobe (ca. 50 mm² for each ear) for 3 consecutive days; the control group was applied the vehicle in the same manner. Five days after the first application, all mice were injected i.v. with ³H-methyl thymidine (³HTdR) and were sacrificed 5 hours later. The draining auricular lymph nodes were excised and pooled per group. Single cell suspensions of pooled lymph nodes were prepared; and ³HTdR incorporation was measured by beta-scintillation counting. A separate positive control study with alpha-hexylcinnamate (5, 10, 25 % (w/v) in acetone:olive oil, 4:1 (v/v) was carried out routinely. The study was conducted in accordance with OECD TG 429 and with GLP guidelines.
No deaths, no clinical symptoms and no adverse effects on body weight were observed. Stimulation index (SI) was 0.91, 0.92, and 0.87 for the groups treated with caffeine at 0.5, 2, and 5%, respectively. An EC3 value was not calculated, since all SI’s were below 3. The positive control study gave the expected results.
In this study, anhydrous caffeine is not a dermal sensitizer.
Migrated from Short description of key information:
Caffeine was not sensitizing in a mouse Local Lymph Node Assay.
Justification for classification or non-classification
There is no need to classify caffeine for sensitization according to GSH criteria or Directive 67/548/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
